Published August 27, 2023 | Version v1

Multiplex proteomic identifies fluid biomarkers for phenoconversion in prodromal and early Parkinson´s Disease

Description

Objective: To evaluate biomarkers in plasma from established cohorts of prodromal synuclein aggregation disorders, including Parkinson’s disease (PD). To identify progression to disease and elucidate the pathophysiology of phenoconversion. This poster was presented in the Movement Disorders Society Conference held in Copenhagen, Denmark in Sept 2023.

 

 

Files

MDS OLINK PARS PPMI DeNoPa Poster20230813 (1).pdf

Files (479.4 kB)

Name Size Download all
md5:790db6236c8ac60b446b2bc9c722f034
479.4 kB Preview Download